ArticleCureus2026
Injectable Vancomycin Contained Within a Hyaluronic Acid-Impregnated Alginate Carrier: A Novel Technique for Prophylaxis Against Surgical Site Infection.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Topical vancomycin powder is used intraoperatively to mitigate the risk of surgical site infection. The method is purported to create supraphysiologic levels of the antibiotic locally, preventing biofilm formation and bacterial colonization, with only a transient effect systemically. However, the concentration and duration of the effect of antibiotics locally remains unclear; concern(s) regarding potential effects on mesenchymal stem cell osteogenic differentiation have been raised and postoperative maceration is not uncommon. The combination of vancomycin with an impregnated carrier processing a gradual dissolution profile over time could theoretically improve efficacy by minimizing any sudden "high concentration burst" and reducing postoperative drainage while prolonging the physiologic levels locally. The purpose of the present article is to describe the author's novel techniques for injectable vancomycin powder contained within a hyaluronic acid-impregnated alginate carrier for prophylaxis against surgical site infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.